- Home
- CRGX vs CTO Comparison
CRGX vs CTO Comparison
Compare CRGX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- CTO
- Stock Information
- Founded
- CRGX 2021
- CTO 1902
- Country
- CRGX United States
- CTO United States
- Employees
- CRGX N/A
- CTO N/A
- Industry
- CRGX
- CTO Real Estate Investment Trusts
- Sector
- CRGX
- CTO Real Estate
- Exchange
- CRGX Nasdaq
- CTO Nasdaq
- Market Cap
- CRGX 628.6M
- CTO 580.9M
- IPO Year
- CRGX 2023
- CTO N/A
- Fundamental
- Price
- CRGX $3.74
- CTO $20.02
- Analyst Decision
- CRGX Hold
- CTO Strong Buy
- Analyst Count
- CRGX 7
- CTO 4
- Target Price
- CRGX $4.67
- CTO $21.50
- AVG Volume (30 Days)
- CRGX 1.9M
- CTO 220.6K
- Earning Date
- CRGX 03-20-2025
- CTO 02-20-2025
- Dividend Yield
- CRGX N/A
- CTO 7.68%
- EPS Growth
- CRGX N/A
- CTO N/A
- EPS
- CRGX N/A
- CTO 0.61
- Revenue
- CRGX N/A
- CTO $118,662,000.00
- Revenue This Year
- CRGX N/A
- CTO N/A
- Revenue Next Year
- CRGX N/A
- CTO $13.12
- P/E Ratio
- CRGX N/A
- CTO $32.77
- Revenue Growth
- CRGX N/A
- CTO 16.61
- 52 Week Low
- CRGX $3.00
- CTO $16.16
- 52 Week High
- CRGX $33.92
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- CRGX 20.88
- CTO 58.60
- Support Level
- CRGX $3.00
- CTO $19.29
- Resistance Level
- CRGX $3.88
- CTO $19.77
- Average True Range (ATR)
- CRGX 0.92
- CTO 0.35
- MACD
- CRGX -1.00
- CTO 0.07
- Stochastic Oscillator
- CRGX 5.99
- CTO 95.40
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.